Edesa Biotechの機関の所有権
Edesa Biotechの機関の所有権は何ですか。
Edesa Biotech, Inc.の機関の所有権は25.36%です。
機関の所有権の定義は何ですか。
機関所有権は、ミューチュアル・ファンドまたは年金基金、保険会社、投資会社、その他の資金を管理する他の団体が所有する会社の株式数です。
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
NASDAQのセクタHealth Careにおける機関の所有権の企業と比べるEdesa Biotech
Edesa Biotechは何をしますか。
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Edesa Biotechと類似の機関の所有権
- Libertine Plcの機関の所有権は25.32%です。
- ICICI Lombard General Insuranceの機関の所有権は25.32%です。
- Balyo SAの機関の所有権は25.33%です。
- Tonix Pharmaceuticalsの機関の所有権は25.33%です。
- Journeo plcの機関の所有権は25.33%です。
- Sun Pharmaceutical Industriesの機関の所有権は25.35%です。
- Edesa Biotechの機関の所有権は25.36%です。
- Calumetの機関の所有権は25.38%です。
- Ferratum Oyjの機関の所有権は25.38%です。
- Vitalharvest Freehold Trustの機関の所有権は25.39%です。
- Servcorpの機関の所有権は25.39%です。
- Galaxy Digitalの機関の所有権は25.39%です。
- Hammond Power Solutionsの機関の所有権は25.39%です。